Source: International Congress 2014 – Clinical presentations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Kapustina, S. Ovcharenko (Moscow, Russian Federation). Gender differences in COPD patients. Eur Respir J 2014; 44: Suppl. 58, 3574

Member's Comments

No comment yet.

Related content which might interest you: The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 The role of COPD in development of osteoporosis Source: International Congress 2014 – Markers Year: 2014 COPD and depression: Prevalence and interaction Source: International Congress 2014 – Comorbidities Year: 2014 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 Mortality predictors in stable COPD Source: International Congress 2014 – Predictors Year: 2014 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Impact of comorbidities in COPD prognosys scores Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 Is clinical presentation different between men and women with COPD? Source: International Congress 2014 – Clinical presentations Year: 2014 Renal impairment a neglected comorbidity in patients with COPD Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Metabolic syndrome in patients with COPD Source: International Congress 2014 – Clinical presentations Year: 2014 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Heterogeneity of group D in the new GOLD classification of COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016